Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade GliomaTimothy F. Cloughesy, Michael A. Vogelbaum, Kevin Petrecca et al.|JAMA Oncology|2020Cited by 144
Rare Genomic Variants Link Bipolar Disorder with Anxiety Disorders to CREB-Regulated Intracellular Signaling PathwaysBerit Kerner, Stanley F. Nelson, Aliz R. Rao et al.|Frontiers in Psychiatry|2013Cited by 44
Rich annotation of DNA sequencing variants by leveraging the Ensembl Variant Effect Predictor with pluginsMichael Yourshaw, Stanley F. Nelson, Martı́n G. Martı́n et al.|Briefings in Bioinformatics|2014Cited by 40
Rare deleterious mutations are associated with disease in bipolar disorder familiesAliz R. Rao, Berit Kerner, Michael Yourshaw et al.|Molecular Psychiatry|2016Cited by 36
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with GliomaWilliam P. Accomando, Derek Ostertag, Aliz R. Rao et al.|Clinical Cancer Research|2020Cited by 29